On 9/13/24, Champions Oncology Inc (NASDAQ: CSBR) stock enjoyed a major increase of 13.2%, closing at $5.05. Moreover, this advance was accompanied by exceptionally high trading volume at 358% of normal. Relative to the market the stock has been weak over the last nine months but has risen 18.8% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be below the cost of capital, CSBR is expected to be a modest Value Eraser.
Champions Oncology is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment